145 related articles for article (PubMed ID: 33867737)
1. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors.
Lokhande T; Thomas S; Kumar G; Bajpai M
Indian J Hematol Blood Transfus; 2021 Apr; 37(2):295-301. PubMed ID: 33867737
[TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of single-donor plateletpheresis by Haemonetics
Baruah S; Bajpai M
Asian J Transfus Sci; 2020; 14(1):23-27. PubMed ID: 33162701
[TBL] [Abstract][Full Text] [Related]
3. Calcium and magnesium levels during automated plateletpheresis in normal donors.
Das SS; Chaudhary R; Khetan D; Shukla JS; Agarwal P; Mishra RB
Transfus Med; 2005 Jun; 15(3):233-6. PubMed ID: 15943708
[TBL] [Abstract][Full Text] [Related]
4. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Patidar GK; Sharma RR; Marwaha N
Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
[TBL] [Abstract][Full Text] [Related]
5. Serial monitoring of ionised calcium levels in plateletpheresis donors: A study from tertiary care oncology centre in India.
Navkudkar A; Desai P; Rajadhyaksha S
Transfus Apher Sci; 2022 Jun; 61(3):103350. PubMed ID: 35012841
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Plateletpheresis on the Haemonetics and Trima Accel Cell Separators.
Keklik M; Keklik E; Kalan U; Ozer O; Arik F; Sarikoc M
Ther Apher Dial; 2018 Feb; 22(1):87-90. PubMed ID: 29082642
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of five plateletpheresis machines in a tertiary care center of India: AmiCORE vs COM.TEC vs Haemonetics MCS+ vs Spectra Optia vs Trima Accel.
Arcot PJ; Kumar K; Coshic P; Andriyas V; Mehta V
J Clin Apher; 2021 Feb; 36(1):41-47. PubMed ID: 32894894
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study.
Pandey PK; Tiwari A; Agarwal N; Dara RC
Asian J Transfus Sci; 2020; 14(1):19-22. PubMed ID: 33162700
[TBL] [Abstract][Full Text] [Related]
9. Comparison of double dose plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC and Trima Accel cell separators.
Keklik M; Eser B; Kaynar L; Solmaz M; Ozturk A; Yay M; Birekul A; Oztekin M; Sivgin S; Cetin M; Unal A
Transfus Apher Sci; 2014 Oct; 51(2):193-6. PubMed ID: 25219639
[TBL] [Abstract][Full Text] [Related]
10. Alteration in biochemical parameters during plateletpheresis in healthy donors: A compendious analysis.
Garg K; Kaur P; Bedi RK; Gupta S
Transfus Clin Biol; 2021 Aug; 28(3):239-245. PubMed ID: 33965622
[TBL] [Abstract][Full Text] [Related]
11. Comparison of plateletpheresis on the Fresenius AS.TEC 204 and Haemonetics MCS 3p.
Ranganathan S
J Clin Apher; 2007 Feb; 22(1):1-4. PubMed ID: 17111420
[TBL] [Abstract][Full Text] [Related]
12. Assessment of pre and post donation changes in hematological parameters and serum calcium and magnesium levels in plateletpheresis donors.
Syal N; Kukar N; Arora H; Kaur A; Handa A; Maharishi RN
J Family Med Prim Care; 2022 Apr; 11(4):1489-1492. PubMed ID: 35516708
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
Picker SM; Radojska SM; Gathof BS
Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
[TBL] [Abstract][Full Text] [Related]
14. Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators.
Keklik M; Eser B; Kaynar L; Sivgin S; Keklik E; Solmaz M; Ozturk A; Buyukoglan R; Yay M; Cetin M; Unal A
J Clin Apher; 2015 Jun; 30(3):171-5. PubMed ID: 25230340
[TBL] [Abstract][Full Text] [Related]
15. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the Trima Accel cell separator in the double dose plateletpheresis.
Keklik M; Korkmaz S; Kalan U; Sarikoc M; Keklik E
Transfus Apher Sci; 2016 Oct; 55(2):240-242. PubMed ID: 27522105
[TBL] [Abstract][Full Text] [Related]
17. First comparison of productivity and citrate donor load between the Trima version 4 (dual-stage filler) and the Trima Accel (single-stage filler) in the same donors.
Ringwald J; Zingsem J; Zimmermann R; Strasser E; Antoon M; Eckstein R
Vox Sang; 2003 Nov; 85(4):267-75. PubMed ID: 14633252
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets.
Keklik M; Keklik E; Korkmaz S; Aygun B; Arik F; Kilic O; Sarikoc M
Transfus Apher Sci; 2015 Dec; 53(3):396-8. PubMed ID: 26283175
[TBL] [Abstract][Full Text] [Related]
19. Plateletpheresis in the Era of Automation: Optimizing Donor Safety and Product Quality Using Modern Apheresis Instruments.
Das SS; Sen S; Zaman RU; Biswas RN
Indian J Hematol Blood Transfus; 2021 Jan; 37(1):134-139. PubMed ID: 33707846
[TBL] [Abstract][Full Text] [Related]
20. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
Alex J; Roberts B; Raife T
J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
